Extramedullary relapse of multiple myeloma defined as the highest risk group based on deregulated gene expression data
Background: Multiple myeloma (MM) is characterized by malignant proliferation of plasma cells (PC) which accumulate in the bone marrow (BM). The advent of new drugs has changed the course of the disease from incurable to treatable, but most patients eventually relapse. One group of MM patients (10-1...
Main Authors: | Sabina Sevcikova, Helena Paszekova, Lenka Besse, Lenka Sedlarikova, Veronika Kubaczkova, Martina Almasi, Ludek Pour, Roman Hajek |
---|---|
Format: | Article |
Language: | English |
Published: |
Palacký University Olomouc, Faculty of Medicine and Dentistry
2015-06-01
|
Series: | Biomedical Papers |
Subjects: | |
Online Access: | https://biomed.papers.upol.cz/artkey/bio-201502-0020_Extramedullary_relapse_of_multiple_myeloma_defined_as_the_highest_risk_group_based_on_deregulated_gene_expressi.php |
Similar Items
-
Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease
by: Xiang Zhou, et al.
Published: (2020-04-01) -
A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones?
by: Uros Markovic, et al.
Published: (2019-09-01) -
Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma
by: JingSong He, et al.
Published: (2021-07-01) -
Relapse of multiple myeloma presenting as extramedullary plasmacytoma surrounding the aorta: A rare case report
by: Omer Ekinci, et al.
Published: (2020-12-01) -
Efficacy of Humanized Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With and Without Extramedullary Disease
by: Haobin Deng, et al.
Published: (2021-08-01)